Events - Spark Newswire

2 minute read

Political Ad Spending For Midterms May Shatter Records: Here Are Some Winners And Losers

Today, 6:21 PM

The 2022 midterm elections are setting up to be the highest-spending political advertising cycle of all time. AdImpact forecasts that upwards of $9.7 billion will be spent on political advertising, revised from $8.9 billion projected in July 2021.

DIS

2 minute read

What Are The Best Psychedelic-Assisted Therapy Clinics In The World? Here Are 5 To Check Out

By Lara Goldstein

Today, 6:21 PM

Psychedelic-Assisted Therapy, or PAT, is the type of treatment in which the delivery of a psychedelic substance -i.e.

FTHWF

2 minute read

5 Philadelphia Fintech Companies To Watch: Venmo, InstaMed And More

By Philip Lloyd

Today, 6:21 PM

Fintech has not only changed the way we do business, but how we lead our daily lives. Millions of times every day, Americans use fintech apps like Venmo and Zelle to send money straight from their phones, or Paypal and TorFx, to conduct business transactions.

PYPL

2 minute read

Looking For A Short Squeeze Candidate: 2 Small Caps With Soaring Yields And Are Heavily Shorted

By Robert Kuczmarski

Today, 6:21 PM

When investing in heavily shorted stocks, it is important to know that floating shares are the number of shares available for trading on a particular stock.

BGFV

1 minute read

Events
News

Wallbox Tweets ‘Get ready, Wallboxers! Something HUGE is happening tomorrow. ‘

By Benzinga Newsdesk

Today, 6:21 PM

https://twitter.com/wallboxchargers/status/1585297639658037248

WBX

1 minute read

Aileron Therapeutics Presents Results From Phase 1 Study In Healthy Volunteers Demonstrating ALRN-6924 Induced Cell Cycle Arrest On Bone Marrow Stem Cells And Hair Follicles At EORTC-NCI-AACR International Conference

By Benzinga Newsdesk

Today, 6:21 PM

p53-mediated cell cycle arrest results demonstrate potential of ALRN-6924 to prevent chemotherapy-induced neutropenia, thrombocytopenia, and anemia, as well as chemotherapy-induced alopecia (hair loss) Study showed

ALRN

4 minute read

Atara Biotherapeutics Presents New MRI And Updated Open-Label Extension Data From Phase 1 Study Of ATA188 In Progressive Multiple Sclerosis At ECTRIMS 2022 October 26-28

By Benzinga Newsdesk

Today, 6:21 PM

Sustained Improvement Observed in ATA188 Treated Patients Achieving Confirmed Disability Improvement (CDI) in Open Label Extension (OLE) with up to 46 Months Follow up Patients Treated with ATA188 that Achieved CDI

ATRA

2 minute read

Stocks Don’t Always Go Up: New Data Reveals Investor Sentiment Is Hovering At Financial Crisis Levels

By Robert Kuczmarski

Today, 6:21 PM

The probability that investors see of stock price gains in the year ahead have plummeted to levels not seen since prior to the 2008 Great Recession.

HOOD

3 minute read

Laguna Labs Launches The World’s First Flatcoin Pegged To The Cost Of Living

By Justin Roberti

Today, 6:21 PM

In a time of record inflation in the U.S., the idea of "flat" has its appeal.

COIN

1 minute read

Immix Biopharma To Present Milestones Achieved To Enable Kick-Off Of 2 IMX-110 Clinical Trials At 2022 ThinkEquity Conference On October 26

By Benzinga Newsdesk

Today, 6:21 PM

Immix Biopharma, Inc. (NASDAQ:IMMX) ("ImmixBio", "Company", "We" or "Us"), a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)™ targeting oncology

IMMB